- Corporate Officers - M
- Myers Scott Dunseth
Insider Trading History of Myers Scott Dunseth
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Myers Scott Dunseth since 2016.
This trader's CIK number is 1356256.
At the time of last reporting, Myers Scott Dunseth was the Director of Dynavax Technologies Corp. (stock ticker symbol DVAX).
Also see all insider trading activities at Dynavax Technologies Corp.
Note that in the past
Myers Scott Dunseth also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cascadian Therapeutics, Inc. (CASC) by Myers Scott Dunseth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | CASC | 0 | $0 | 0 | $0 | 10,500 | $0 |
| 2017 | CASC | 31,800 | $120,927 | 0 | $0 | 0 | $0 |
| 2016 | CASC | 107,500 | $101,749 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zentalis Pharmaceuticals, Inc. (ZNTL) by Myers Scott Dunseth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ZNTL | 21,000 | $29,379 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Viridian Therapeutics, Inc.\de (VRDN) by Myers Scott Dunseth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | VRDN | 9,500 | $261,805 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dynavax Technologies Corp (DVAX) by Myers Scott Dunseth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | DVAX | 3,800 | $41,116 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Myers Scott Dunseth:
1. Cascadian Therapeutics, Inc. (CASC)
2. Zentalis Pharmaceuticals, Inc. (ZNTL)
3. Viridian Therapeutics, Inc.\de (VRDN)
4. Dynavax Technologies Corp (DVAX)
Table 1. Insider trading of Cascadian Therapeutics, Inc. (CASC) by Myers Scott Dunseth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-01-11 | CASC | Option Ex | 10,500 | .00 | 0 |
| 2017-08-11 | CASC | Buy | 5,500 | 3.73 | 20,542 |
| 2017-05-12 | CASC | Buy | 2,800 | 4.00 | 11,191 |
| 2017-03-31 | CASC | Buy | 2,000 | 4.11 | 8,228 |
| 2017-03-20 | CASC | Buy | 1,000 | 3.93 | 3,927 |
| 2017-01-27 | CASC | Buy | 20,500 | 3.76 | 77,039 |
| 2016-08-17 | CASC | Buy | 45,000 | 1.15 | 51,749 |
| 2016-06-28 | CASC | Buy | 62,500 | .80 | 50,000 |
Table 2. Insider trading of Zentalis Pharmaceuticals, Inc. (ZNTL) by Myers Scott Dunseth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-04-30 | ZNTL | Buy | 21,000 | 1.40 | 29,379 |
Table 3. Insider trading of Viridian Therapeutics, Inc.\de (VRDN) by Myers Scott Dunseth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-12 | VRDN | Buy | 4,000 | 25.37 | 101,480 |
| 2023-03-13 | VRDN | Buy | 5,500 | 29.15 | 160,325 |
Table 4. Insider trading of Dynavax Technologies Corp (DVAX) by Myers Scott Dunseth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-22 | DVAX | Buy | 3,800 | 10.82 | 41,116 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Myers Scott Dunseth
(Director of Dynavax Technologies Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.